M&T Bank Corp Sells 6,361 Shares of Certara, Inc. (NASDAQ:CERT)

M&T Bank Corp lowered its position in shares of Certara, Inc. (NASDAQ:CERT) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 135,007 shares of the company’s stock after selling 6,361 shares during the quarter. M&T Bank Corp’s holdings in Certara were worth $2,375,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Motley Fool Asset Management LLC boosted its position in shares of Certara by 2.0% during the 3rd quarter. Motley Fool Asset Management LLC now owns 45,890 shares of the company’s stock worth $667,000 after purchasing an additional 890 shares in the last quarter. Natixis Advisors L.P. boosted its position in shares of Certara by 13.4% during the 3rd quarter. Natixis Advisors L.P. now owns 15,136 shares of the company’s stock worth $220,000 after purchasing an additional 1,791 shares in the last quarter. Truist Financial Corp boosted its position in shares of Certara by 20.5% during the 4th quarter. Truist Financial Corp now owns 13,958 shares of the company’s stock worth $246,000 after purchasing an additional 2,372 shares in the last quarter. Swiss National Bank boosted its position in shares of Certara by 1.1% during the 3rd quarter. Swiss National Bank now owns 263,600 shares of the company’s stock worth $3,833,000 after purchasing an additional 2,900 shares in the last quarter. Finally, Zions Bancorporation N.A. boosted its position in shares of Certara by 9.1% during the 3rd quarter. Zions Bancorporation N.A. now owns 36,717 shares of the company’s stock worth $534,000 after purchasing an additional 3,054 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CERT. Barclays increased their price objective on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. UBS Group upped their target price on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a report on Friday, March 1st. Jefferies Financial Group upped their target price on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a report on Friday, March 1st. Leerink Partnrs restated a “market perform” rating on shares of Certara in a report on Monday, February 26th. Finally, JMP Securities started coverage on shares of Certara in a report on Thursday, April 4th. They issued a “market perform” rating on the stock. Seven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Certara currently has an average rating of “Hold” and a consensus price target of $20.06.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 14,427 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, insider Patrick F. Smith sold 14,427 shares of the firm’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares in the company, valued at approximately $844,033.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Richard M. Traynor sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock worth $405,095 in the last quarter. Insiders own 2.39% of the company’s stock.

Certara Trading Down 7.4 %

NASDAQ:CERT opened at $16.35 on Thursday. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62. The firm has a market cap of $2.62 billion, a price-to-earnings ratio of -46.71, a price-to-earnings-growth ratio of 1.81 and a beta of 1.61. Certara, Inc. has a 52 week low of $11.81 and a 52 week high of $22.65. The firm has a 50-day moving average price of $17.72 and a two-hundred day moving average price of $16.44.

Certara (NASDAQ:CERT) last posted its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). The firm had revenue of $88.01 million during the quarter, compared to analysts’ expectations of $86.80 million. Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. On average, equities analysts expect that Certara, Inc. will post 0.29 earnings per share for the current fiscal year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.